PUMA BIOTECHNOLOGY INC (PBYI) is a publicly traded Healthcare sector company. As of November 4, 2026, PBYI trades at $10.48 with a market cap of $527.56M and a P/E ratio of 18.40. PBYI moved +4.60% today. Year to date, PBYI is +79.97%; over the trailing twelve months it is +118.16%. Its 52-week range spans $2.58 to $11.50. Analyst consensus is neutral with an average price target of $6.00. Rallies surfaces PBYI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PBYI shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $10.48 |
| Market Cap | $527.56M |
| P/E Ratio | 18.40 |
| EPS | $0.54 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.50 |
| 52-Week Low | $2.58 |
| Volume | 385.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $231.24M |
| Net Income | $26.72M |
| Gross Margin | 74.83% |
1 analysts cover PBYI: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $6.00.